Medications

Glaxo in $350mln cancer deal with biotech specialist

British pharmaceuticals giant GlaxoSmithKline has agreed a $350-million deal with Adaptimmune to help develop and sell the biotechnology firm's cancer drugs, the companies said on Monday.

Medications

Embattled GlaxoSmithKline hit with another fraud probe

Britain's fraud agency on Tuesday said it had launched a probe into pharmaceutical giant GlaxoSmithKline, which is already subject of a series of investigations into alleged staff corruption.

Medications

Probe-hit GlaxoSmithKline announces profits slump

GlaxoSmithKline, the British drugs giant facing a series of probes into alleged staff corruption, announced sliding profits on Wednesday, one week after unveiling a group makeover.

Medications

China crystal meth makers used GSK cold medicine: report

Some crystal methamphetamine seized in a huge drug bust in China used the popular cold medicine Contac, manufactured by beleaguered British drugmaker GlaxoSmithKline (GSK), state media reported Tuesday.

Medications

GSK to scrap individual sales targets (Update)

British drug company GlaxoSmithKline said Tuesday it would stop paying doctors to promote its products at speaking engagements and scrap individual sales targets, months after its ethics were challenged by a bribery scandal ...

Medications

Novartis probes corruption claims in Chinese press

Swiss pharmaceutical giant Novartis announced Tuesday it has opened an internal inquiry following Chinese press accusations of corruption at its Alcon eye care division.

page 6 from 8